Market News: Director of South Korea's National Police Agency will be arrested.Nearly 30 listed companies announced after-hours that their products would be selected, and the tenth batch of centralized drug procurement (centralized drug procurement) organized by the state was opened in Shanghai yesterday. According to incomplete statistics, as of press time, it includes Fuyuan Pharmaceutical, Yifan Pharmaceutical, ST Tiansheng, Hokuriku Pharmaceutical, Haizheng Pharmaceutical, Zhongheng Group, Yuandong Bio, Kelun Pharmaceutical, China Resources Shuanghe, Sinopharm Modern, Lingkang Pharmaceutical, Xuantai Pharmaceutical, Jiuzhou Pharmaceutical, Kang Enbei, Laimei Pharmaceutical, Kanghong Pharmaceutical, Huasen Pharmaceutical, Borui Pharmaceutical, Xianzeng Pharmaceutical. Among them, Kelun Pharmaceutical announced that 12 kinds of drugs, such as sodium acetate Ringer injection, sodium bicarbonate Ringer injection and gliclazide tablets, were to be selected.GCL Technology: It is estimated that there will be no more share repurchase cancellation in 2024. GCL Technology (03800) announced that in view of the fact that the photovoltaic industry is still in excessive competition, in order to ensure the stability of the company's operation and cope with the uncertainty in the future, the company expects that there will be no more share repurchase cancellation in the year ending December 31, 2024.
The Baltic dry bulk freight index fell 0.38% to 1051 points.China International Economic Exchange Center held the annual economic conference in China on December 14th, attended by Han Wenxiu of China Finance Office, and the annual economic conference in China on December 14th, with the theme of implementing the spirit of the Central Economic Work Conference and promoting sustained economic recovery. Han Wenxiu from Zhongcai Office, Zhao Chenxin, Deputy Director of National Development and Reform Commission, Sheng Qiuping, Vice Minister of Commerce, and Wang xin, Director of Research Bureau of China People's Bank will give keynote speeches. (China International Economic Exchange Center)Kexing launched the world's first phase III clinical study of bivalent inactivated enterovirus vaccine. On December 13th, the first volunteer was enrolled in the phase III clinical study of bivalent inactivated enterovirus vaccine developed by Beijing Kexing Biological Products Co., Ltd., a subsidiary of Kexing Holding Biotechnology Co., Ltd. (hereinafter referred to as "Kexing"). The vaccine is used to prevent hand, foot and mouth disease caused by enterovirus 71 (EV71) and coxsackie virus 16 (CA16). A multicenter, randomized, double-blind, controlled study design was adopted in this phase III clinical study to evaluate the protective efficacy, safety and immunogenicity of the vaccine in children aged 6-71 months.
State-owned Assets Supervision and Administration Commission (SASAC): Actively expand effective investment, improve investment efficiency, and focus on the layout of a number of major projects with strong traction and long-term benefits. The Party Committee of the State Council SASAC held a special meeting. The meeting stressed that it is necessary to promote central enterprises to improve their ability to cope with cyclical fluctuations, continue to exert efforts in performance appraisal, quality improvement and efficiency improvement, and economic operation, and strive to simultaneously improve efficiency and efficiency indicators, and strive to achieve development with stronger scientific and technological attributes and greater driving role; Actively expand effective investment, improve investment efficiency, focus on "two" and "two new" layout of a number of major projects with strong traction and long-term benefits; We will do a better job in helping small and medium-sized enterprises, promote central enterprises to deepen strategic cooperation in the industrial chain, take the lead in paying off debts owed by private enterprises, and go all out to stabilize employment, supply and flow, so as to better help the national economy continue to pick up. It is necessary to promote the central enterprises to improve the supply capacity of common technologies, further highlight the key points and strengthen the key core technologies, especially in areas with large investment and long cycle; Further highlight the original innovation, explore and create a "policy enclave", strengthen the applied basic research, and deeply root the "root technology"; Further highlight the transformation of achievements, promote the construction of a number of major pilot projects by central enterprises, and constantly open up the "last mile" of the transformation of scientific and technological achievements into real productive forces, so as to better help high-level science and technology stand on its own feet. (SASAC)Ma Zhaoxu, Vice Minister of Foreign Affairs met with New Zealand Ambassador to China Maury, and Ma Zhaoxu, Vice Minister of Foreign Affairs met with outgoing New Zealand Ambassador to China Maury. Ma Zhaoxu said that under the strategic guidance of the leaders of the two countries, China-Singapore relations have maintained sound development, and mutual benefit and win-win have become the main tone of bilateral relations. The two sides should jointly implement the important consensus of the leaders of the two countries and promote the continued healthy and stable development of China-Singapore comprehensive strategic partnership. Mao Rui said that New Zealand is willing to strengthen dialogue and communication with China and push forward bilateral relations. (Ministry of Foreign Affairs)On December 13th, Jiangsu Securities Regulatory Bureau issued an announcement that Yan Zhen had privately accepted the entrustment of customers to buy and sell securities during his tenure in the securities business department of Xuzhou Jianguo West Road of CITIC Securities (formerly known as the securities business department of Xuzhou Jiefang South Road of CITIC Securities). In violation of regulations, she was supervised to issue a warning letter and recorded it in the integrity file of the securities and futures market.